These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 420210)

  • 1. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and warfarin: use of anticoagulants in the prevention and treatment of venous thrombosis and pulmonary embolism.
    Rosen RL
    J Fam Pract; 1979 May; 8(5):923-7. PubMed ID: 438753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
    Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician practices in the treatment of pulmonary embolism and deep venous thrombosis.
    Wheeler AP; Jaquiss RD; Newman JH
    Arch Intern Med; 1988 Jun; 148(6):1321-5. PubMed ID: 3377615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts of anticoagulation therapy.
    Hull RD; Pineo GF
    Clin Chest Med; 1995 Jun; 16(2):269-80. PubMed ID: 7656539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Audit of start of anticoagulation treatment in inpatients.
    Tan G; Cohen H; Taylor F; Gabbay J
    J Clin Pathol; 1993 Jan; 46(1):67-71. PubMed ID: 8432893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant therapy for deep vein thrombosis: its proper application.
    Rohrer MJ; Anderson FA
    Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time.
    Groce JB; Gal P; Douglas JB; Steuterman MC
    Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of deep vein thrombosis.
    Turpie AG
    Herz; 1989 Dec; 14(6):341-7. PubMed ID: 2695442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of established deep vein thrombosis: a review of the therapeutic armamentarium.
    Berkowitz SD
    Orthopedics; 1995 Jul; 18 Suppl():18-20. PubMed ID: 7479421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolic disease: diagnosis and use of antithrombotic therapy.
    Hyers TM
    Clin Cardiol; 1990 Apr; 13(4 Suppl 6):VI23-8. PubMed ID: 2191812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the management of deep vein thrombosis in patients with spinal cord injury. Part II: a critical evaluation of the anticoagulant therapy.
    Perkash A
    Paraplegia; 1980 Feb; 18(1):2-14. PubMed ID: 6966387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The successful application of a heparin nomogram in a community hospital.
    Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM
    Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol.
    Saya FG; Coleman LT; Martinoff JT
    Am J Hosp Pharm; 1985 Sep; 42(9):1965-9. PubMed ID: 4050813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis.
    Tenero DM; Bell HE; Deitz PA; Bertino JS
    Clin Pharm; 1989 Jan; 8(1):40-3. PubMed ID: 2912663
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulants and thrombolysis in the treatment of pulmonary embolism.
    Raskob GE
    Curr Opin Pulm Med; 1995 Jul; 1(4):291-7. PubMed ID: 9363067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of anticoagulant therapy in deep venous thrombosis in the lower limb in elderly, mobilized patients. A double-blind placebo controlled study with open therapeutic guidance].
    Ott P; Eldrup E; Oxholm P
    Ugeskr Laeger; 1988 Jan; 150(4):218-21. PubMed ID: 3287734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.